High Pointe Capital Management’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-27,380
| Closed | -$1.5M | – | 87 |
|
|
2020
Q3 | $1.5M | Sell |
27,380
-400
| -1% | -$21.9K | 1.82% | 19 |
|
|
2020
Q2 | $1.47M | Sell |
27,780
-2,220
| -7% | -$117K | 1.93% | 19 |
|
|
2020
Q1 | $1.34M | Buy |
30,000
+700
| +2% | +$31.3K | 1.91% | 20 |
|
|
2019
Q4 | $1.46M | Hold |
29,300
| – | – | 1.73% | 24 |
|
|
2019
Q3 | $1.31M | Sell |
29,300
-340
| -1% | -$15.2K | 1.79% | 19 |
|
|
2019
Q2 | $1.22M | Hold |
29,640
| – | – | 1.71% | 20 |
|
|
2019
Q1 | $1.2M | Sell |
29,640
-2,140
| -7% | -$86.5K | 1.64% | 22 |
|
|
2018
Q4 | $1.21M | Buy |
31,780
+980
| +3% | +$37.2K | 1.99% | 13 |
|
|
2018
Q3 | $1.22M | Sell |
30,800
-1,240
| -4% | -$49.1K | 1.64% | 27 |
|
|
2018
Q2 | $1.13M | Buy |
32,040
+13,700
| +75% | +$481K | 1.6% | 27 |
|
|
2018
Q1 | $641K | Buy |
18,340
+1,280
| +8% | +$44.7K | 0.88% | 48 |
|
|
2017
Q4 | $592K | Hold |
17,060
| – | – | 0.81% | 46 |
|
|
2017
Q3 | $578K | Buy |
17,060
+1,420
| +9% | +$48.1K | 0.85% | 46 |
|
|
2017
Q2 | $533K | Buy |
15,640
+3,870
| +33% | +$132K | 0.83% | 50 |
|
|
2017
Q1 | $367K | Hold |
11,770
| – | – | 0.58% | 55 |
|
|
2016
Q4 | $322K | Sell |
11,770
-490
| -4% | -$13.4K | 0.53% | 55 |
|
|
2016
Q3 | $403K | Hold |
12,260
| – | – | 0.72% | 49 |
|
|
2016
Q2 | $370K | Buy |
12,260
+3,960
| +48% | +$120K | 0.56% | 57 |
|
|
2016
Q1 | $234K | Buy |
+8,300
| New | +$234K | 0.34% | 63 |
|